Pharmacotherapy of type 2 diabetes: An updateJagriti Upadhyay, Christos S. Mantzoros, Stergios A. Pοlyzos et al.|Metabolism|2017Cited by 187
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitisStergios A. Pοlyzos, Christos S. Mantzoros, Eun Seok Kang et al.|Metabolism|2020Cited by 136
Effects of leptin and adiponectin on pancreatic β-cell functionYong‐ho Lee, Eun Seok Kang, Faidon Magkos et al.|Metabolism|2011Cited by 128
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular RiskEugene Han, Seung Up Kim, Eun Seok Kang et al.|The American Journal of Gastroenterology|2020Cited by 112
Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy inductionHye Jin Wang, Eun Seok Kang|Autophagy|2015Cited by 57